These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33206322)

  • 1. Introduction to the Special Section: COVID-19 - insights on pharmacology and pharmacotherapy.
    Sanak M
    Pharmacol Rep; 2020 Dec; 72(6):1445. PubMed ID: 33206322
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 virus infection: Targets and antiviral pharmacological strategies.
    Campos DMO; Fulco UL; de Oliveira CBS; Oliveira JIN
    J Evid Based Med; 2020 Nov; 13(4):255-260. PubMed ID: 33058394
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose Selection in a Pandemic: A Framework Informed by the FDA Animal Rule.
    Wu K; Bergman KL
    Clin Transl Sci; 2021 Jan; 14(1):5-7. PubMed ID: 33201590
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.
    Imai M; Ito M; Kiso M; Yamayoshi S; Uraki R; Fukushi S; Watanabe S; Suzuki T; Maeda K; Sakai-Tagawa Y; Iwatsuki-Horimoto K; Halfmann PJ; Kawaoka Y
    N Engl J Med; 2023 Jan; 388(1):89-91. PubMed ID: 36476720
    [No Abstract]   [Full Text] [Related]  

  • 5. Update to living systematic review on drug treatments for covid-19.
    BMJ; 2020 Dec; 371():m4852. PubMed ID: 33334735
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak.
    Tandon N; Luxami V; Tandon R; Paul K
    Mini Rev Med Chem; 2021; 21(8):952-968. PubMed ID: 33234101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Hopes for Drugs against COVID-19 Come from the Sea.
    Taglialatela-Scafati O
    Mar Drugs; 2021 Feb; 19(2):. PubMed ID: 33670191
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Brown RE; Tahseen D
    Ann Clin Lab Sci; 2020 Nov; 50(6):837-841. PubMed ID: 33334802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2.
    Jiang S; Zhang X; Du L
    Expert Opin Ther Targets; 2021 Jun; 25(6):415-421. PubMed ID: 32941780
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment.
    Martinez MA
    Front Immunol; 2021; 12():635371. PubMed ID: 33777024
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic potential for clomiphene, a selective estrogen receptor modulator, in the treatment of COVID-19.
    Ghasemnejad-Berenji M; Pashapour S; Ghasemnejad-Berenji H
    Med Hypotheses; 2020 Dec; 145():110354. PubMed ID: 33129007
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV.
    Aherfi S; Pradines B; Devaux C; Honore S; Colson P; Scola B; Raoult D
    Future Microbiol; 2021 Nov; 16():1341-1370. PubMed ID: 34755538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New SARS-CoV-2 Variants Challenge Vaccines Protection.
    Soriano V; Fernández-Montero JV
    AIDS Rev; 2021 Feb; 23(1):57-58. PubMed ID: 33750742
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthetic and Semi-synthetic Drugs as a Promising Therapeutic Option for the Treatment of COVID-19.
    Shirbhate E; Patel P; Patel VK; Veerasamy R; Sharma PC; Sinha BN; Rajak H
    Mini Rev Med Chem; 2021; 21(8):1004-1016. PubMed ID: 33280595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug repurposing approach to combating coronavirus: Potential drugs and drug targets.
    Xu J; Xue Y; Zhou R; Shi PY; Li H; Zhou J
    Med Res Rev; 2021 May; 41(3):1375-1426. PubMed ID: 33277927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An EUA for sotrovimab for treatment of COVID-19.
    Med Lett Drugs Ther; 2021 Jun; 63(1627):97-xx98. PubMed ID: 34181630
    [No Abstract]   [Full Text] [Related]  

  • 17. Statins as candidate therapeutic agents for coronavirus disease 2019 (COVID-19).
    Li SD; Zhang SY; Peng B
    Chin Med J (Engl); 2020 Nov; 134(4):407-409. PubMed ID: 33617183
    [No Abstract]   [Full Text] [Related]  

  • 18. Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
    Edwards AM; Baric RS; Saphire EO; Ulmer JB
    Science; 2022 Mar; 375(6585):1133-1139. PubMed ID: 35271333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine.
    Guan W; Lan W; Zhang J; Zhao S; Ou J; Wu X; Yan Y; Wu J; Zhang Q
    Virol Sin; 2020 Dec; 35(6):685-698. PubMed ID: 32997322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment.
    Kate Gadanec L; Qaradakhi T; Renee McSweeney K; Ashiana Ali B; Zulli A; Apostolopoulos V
    Future Microbiol; 2021 Mar; 16():205-209. PubMed ID: 33569984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.